[Clinical Significance of Extranodal Extension in Non-small Cell Lung Cancer: Current Status and Future Prospects].
Global cancer statistics in 2022 ranked lung cancer as the leading cause of cancer incidence and mortality worldwide, with lymph node metastasis serving as a pivotal determinant of prognosis and treat
APA
Liang H, Meng Y, et al. (2026). [Clinical Significance of Extranodal Extension in Non-small Cell Lung Cancer:
Current Status and Future Prospects].. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 29(1), 47-58. https://doi.org/10.3779/j.issn.1009-3419.2026.101.03
MLA
Liang H, et al.. "[Clinical Significance of Extranodal Extension in Non-small Cell Lung Cancer:
Current Status and Future Prospects].." Zhongguo fei ai za zhi = Chinese journal of lung cancer, vol. 29, no. 1, 2026, pp. 47-58.
PMID
41916914
Abstract
Global cancer statistics in 2022 ranked lung cancer as the leading cause of cancer incidence and mortality worldwide, with lymph node metastasis serving as a pivotal determinant of prognosis and treatment strategy. Extranodal extension (ENE) refers to the pathological phenomenon where tumor cells breach the lymph node capsule and invade surrounding tissues. In non-small cell lung cancer (NSCLC), although ENE has not yet been formally incorporated into the tumor-node-metastasis (TNM) staging system, its clinical value is gaining increasing attention. This review systematically summarizes the current research progress regarding the definition, diagnostic approaches, prognostic significance, and treatment implications of ENE in NSCLC, analyzes existing challenges, and proposes future directions. The goal of this paper is to provide insights for optimizing clinical practice and guiding subsequent research.
.
MeSH Terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Extranodal Extension; Prognosis; Neoplasm Staging; Clinical Relevance
같은 제1저자의 인용 많은 논문 (5)
- Development and Validation of Claims-Based Algorithms for Non-Melanoma Skin Cancer in Patients With Psoriasis Using Optum Market Clarity.
- Trastuzumab deruxtecan in advanced breast cancer: a real-world study of efficacy and safety in Chinese cohort with HER2-positive and HER2-low expression.
- Association Between Peripheral Blood Lymphocyte Count and HER2 Status in Breast Cancer: A Retrospective Study.
- Identifying a better-prognosis pancreatic cancer from its benign inflammatory mimic: a machine learning approach with contrast-enhanced ultrasound for early intervention.
- Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer.